Renal Cancer - Results from #3300

Patient Enrollment Completed in Calithera Biosciences Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma October 4, 2019

Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava. October 3, 2019

LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA‑942. October 3, 2019

Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways. October 3, 2019

Robotic partial nephrectomy versus radical nephrectomy in elderly patients with large renal masses. October 3, 2019

Bioinformatics Analysis Suggests the Combined Expression of AURKB and KIF18B Being an Important Event in the Development of Clear Cell Renal Cell Carcinoma. October 2, 2019

Synchronous retroperitoneal Castleman's disease with clear cell renal cell carcinoma. October 2, 2019

Elevated CD36 expression correlates with increased visceral adipose tissue and predicts poor prognosis in ccRCC patients. October 2, 2019

Targeting lysosome function causes selective cytotoxicity in VHL-inactivated renal cell carcinomas. October 1, 2019

A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy. October 1, 2019

Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment. October 1, 2019

Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma. September 30, 2019

Imaging of Small Renal Masses before and after Thermal Ablation. September 30, 2019

Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy. September 30, 2019

Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma. September 27, 2019

Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis. September 27, 2019

Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of Survival. September 27, 2019

Very late locally recurrent chromophobe renal cell carcinoma: 15 years following radical nephrectomy for low-stage disease. September 26, 2019

Transcription factor SOX18 promotes clear cell renal cell carcinoma progression and alleviates cabozantinib-mediated inhibitory effects. September 26, 2019

Stage-specific conditional survival in renal cell carcinoma after nephrectomy. September 26, 2019

Page 166 of 457